Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001076809-25-000106
Filing Date
2025-09-10
Accepted
2025-09-10 14:34:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7480
  Complete submission text file 0001076809-25-000106.txt   9251
Mailing Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019 212-808-7308
GLAZER CAPITAL, LLC (Filed by) CIK: 0001076809 (see all company filings)

EIN.: 134032491 | State of Incorp.: DE
Type: SCHEDULE 13G

Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Subject) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90193 | Film No.: 251305521
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)